Keyes Katherine M, Rutherford Caroline, Hamilton Ava, Palamar Joseph J
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA; Department of Psychiatry, Columbia University Medical Center, New York, NY, USA.
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Drug Alcohol Depend. 2016 Sep 1;166:159-67. doi: 10.1016/j.drugalcdep.2016.07.018. Epub 2016 Jul 28.
Synthetic cannabinoids use has been a public health concern given association with hospitalization and death among users. While national reports estimate that reported use is declining among adolescents, differences by birth cohort may indicate subgroups who remain at higher risk, both in the overall adolescent population and among demographic subgroups.
We estimated age, period, and cohort models of self-reported past-year synthetic cannabinoid use (queried as "synthetic marijuana" ["K2," "Spice"]) among 54,865 adolescents aged 13-19 attending high school from 2011 to 2015.
Past-year use decreased from 11.86% in 2011 to 4.75% in 2015. This decrease was best represented as a linear downward trend. When stratified by key covariates, however, results indicated evidence of a positive cohort effect for students of higher socioeconomic status (SES). For those students, use did not decrease at the same rate as the overall population; younger cohorts of high SES students remain at higher risk for synthetic cannabinoid use than older cohorts as well as lower SES peers. A similar and stronger association was found for frequent marijuana users (≥20 occasions of past-year use). Multi-level models indicated that groups at highest risk included older adolescents, Hispanics and other/mixed race students, cigarette users, and frequent marijuana users.
Synthetic cannabinoid use is associated with morbidity as well as mortality; continued attention to reducing synthetic cannabinoid use remains an important public health priority to maximizing student health.
鉴于合成大麻素的使用与使用者的住院和死亡有关,其已成为一个公共卫生问题。虽然国家报告估计青少年中报告的使用量在下降,但不同出生队列之间的差异可能表明在整个青少年人群以及人口亚组中仍处于较高风险的亚组。
我们估计了2011年至2015年期间54,865名13至19岁就读高中的青少年中过去一年自我报告的合成大麻素使用情况(询问为“合成大麻”[“K2”,“香料”])的年龄、时期和队列模型。
过去一年的使用率从2011年的11.86%降至2015年的4.75%。这种下降最好表示为线性下降趋势。然而,按关键协变量分层时,结果表明社会经济地位较高(SES)的学生存在正向队列效应。对于那些学生,使用率下降的速度与总体人群不同;高SES学生的年轻队列使用合成大麻素的风险仍高于年长队列以及低SES同龄人。对于频繁使用大麻的人(过去一年使用≥20次),发现了类似且更强的关联。多层次模型表明,风险最高的群体包括年龄较大的青少年、西班牙裔和其他/混合种族的学生、吸烟的学生以及频繁使用大麻的人。
合成大麻素的使用与发病率和死亡率相关;持续关注减少合成大麻素的使用仍然是最大化学生健康的重要公共卫生优先事项。